9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901

Asim Amin, Susan Halabi, Edward P. Gelmann, Walter Stadler, Nicholas Vogelzang, Eric Small

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of '9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901'. Together they form a unique fingerprint.

Medicine & Life Sciences